274 related articles for article (PubMed ID: 17932321)
1. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
Nangaku M; Izuhara Y; Takizawa S; Yamashita T; Fujii-Kuriyama Y; Ohneda O; Yamamoto M; van Ypersele de Strihou C; Hirayama N; Miyata T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2548-54. PubMed ID: 17932321
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
4. Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase.
Tsukiyama F; Nakai Y; Yoshida M; Tokuhara T; Hirota K; Sakai A; Hayashi H; Katsumata T
Biochem Biophys Res Commun; 2006 Dec; 351(1):234-9. PubMed ID: 17056012
[TBL] [Abstract][Full Text] [Related]
5. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
[TBL] [Abstract][Full Text] [Related]
6. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl-quinolone derivatives inhibit hypoxia inducible factor-1α prolyl hydroxylases-1, -2, and -3 with altered selectivity.
Murray JK; Balan C; Allgeier AM; Kasparian A; Viswanadhan V; Wilde C; Allen JR; Yoder SC; Biddlecome G; Hungate RW; Miranda LP
J Comb Chem; 2010 Sep; 12(5):676-86. PubMed ID: 20666436
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologically induced angiogenesis in transgenic zebrafish.
Raghunath M; Sy Wong Y; Farooq M; Ge R
Biochem Biophys Res Commun; 2009 Jan; 378(4):766-71. PubMed ID: 19068208
[TBL] [Abstract][Full Text] [Related]
9. Effects of polynitrogen compounds on the activity of recombinant human HIF-1α prolyl hydroxylase 3 in E. coli.
Geng Z; Zhu J; Cao J; Geng J; Song X; Zhang Z; Bian N; Wang Z
J Inorg Biochem; 2011 Mar; 105(3):391-9. PubMed ID: 21421125
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
13. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
Takeda K; Cowan A; Fong GH
Circulation; 2007 Aug; 116(7):774-81. PubMed ID: 17646578
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart.
Rohrbach S; Simm A; Pregla R; Franke C; Katschinski DM
Biogerontology; 2005; 6(3):165-71. PubMed ID: 16041620
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor.
Barrett TD; Palomino HL; Brondstetter TI; Kanelakis KC; Wu X; Haug PV; Yan W; Young A; Hua H; Hart JC; Tran DT; Venkatesan H; Rosen MD; Peltier HM; Sepassi K; Rizzolio MC; Bembenek SD; Mirzadegan T; Rabinowitz MH; Shankley NP
Mol Pharmacol; 2011 Jun; 79(6):910-20. PubMed ID: 21372172
[TBL] [Abstract][Full Text] [Related]
16. In vivo functions of the prolyl-4-hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues.
Katschinski DM
Acta Physiol (Oxf); 2009 Apr; 195(4):407-14. PubMed ID: 19183336
[TBL] [Abstract][Full Text] [Related]
17. Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity.
Wirthner R; Balamurugan K; Stiehl DP; Barth S; Spielmann P; Oehme F; Flamme I; Katschinski DM; Wenger RH; Camenisch G
Methods Enzymol; 2007; 435():43-60. PubMed ID: 17998048
[TBL] [Abstract][Full Text] [Related]
18. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors.
Tug S; Delos Reyes B; Fandrey J; Berchner-Pfannschmidt U
Biochem Biophys Res Commun; 2009 Jul; 384(4):519-23. PubMed ID: 19427832
[TBL] [Abstract][Full Text] [Related]
19. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
[TBL] [Abstract][Full Text] [Related]
20. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.
Baek JH; Reiter CE; Manalo DJ; Buehler PW; Hider RC; Alayash AI
Biochim Biophys Acta; 2011; 1809(4-6):262-8. PubMed ID: 21558026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]